Algernon Pharmaceuticals Announces Green Light From Data and Safety Monitoring Board to Continue its Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19

Algernon Pharmaceuticals Announces Green Light From Data and Safety Monitoring Board to Continue its Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19

VANCOUVER, British Columbia, Oct. 30, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.&nb...
read more
Study finds Oregon workplace safety monitoring needs to be more timely to help workers

Study finds Oregon workplace safety monitoring needs to be more timely to help workers

A recent study evaluating the effectiveness of Ore...
read more
In-home passive monitoring can help seniors stay independent

In-home passive monitoring can help seniors stay independent

The shift toward “aging in place” has ...
read more
Electronic Order Set May Reduce Inappropriate ECG Monitoring

Electronic Order Set May Reduce Inappropriate ECG Monitoring

WEDNESDAY, March 6, 2019 — Use of electronic...
read more